HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

925.265

-8.623-0.92%

Number of Gainers:2

Number of Losers:15

Number of Flat:- -

PE:- -

High:930.611

Open:930.611

Low:904.457

Close:933.888

Volume:536.53M

Turnover:4.82B

Market Cap:620.70B

Float Cap:517.91B

Loading ...

Iceland's Alvotech H1 Revenue Falls 31% on Manufacturing Program

Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback

Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million

Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million

Kintor Pharmaceutical H1 Revenue RMB 52 Million

THOMSON REUTERS

Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation

Sinopharm Group and Partners to Divest 51% Stake in Guorui Pharma for RMB 406 Million

Sinopharm Sells 30.13% Stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 Million

Sinopharm Group - to Sell 30.13% Stake in China National Medicines Guorui Pharmaceutical for Rmb240.0731 Mln

THOMSON REUTERS

Regulator Approves New Audit Officer for Ping An Health Insurance Unit

Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments

Sino Biopharmaceutical - Launches New Global Brand Sbp Group

THOMSON REUTERS

Ping An Healthcare And Technology (SEHK:1833) Stock Sinks As Profitability Improves

Simply Wall St.

China Biopharmaceuticals (01177) Mid-Year Review: Betting Big on AI and Global Expansion as Twin Growth Engines

SINOPHARM Reports Mid-Year Results for Its Medical Device Unit

China National Medical Device, Sinopharm Subsidiary, Posts H1 Operating Profit Down 12.34% to RMB 599.37 Million

BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths

CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors

Sino Biopharm Declares 2026 Interim Dividend of HKD 0.07 a Share

Sino Biopharmaceutical H1 Revenue RMB 1,944 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1515/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":925.2649,"timestamp":1788163726135,"preClose":933.88794,"halted":0,"volume":536532085,"delay":0,"changeRate":-0.009233,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-8.623047,"latestTime":"08-31 16:00:00","open":930.611,"high":930.611,"low":904.4565,"amount":4819960565.96,"amplitude":0.028006,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"pbRate":1.403188,"peRate":17.015388,"turnoverRate":0.006128,"increases":2,"decrements":15,"flats":0,"marketCap":620699252288,"floatMarketCap":517907756096},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":930.611,"amplitude":0.028006,"preClose":933.88794,"low":904.4565,"pbRate":"1.403188","latestPrice":925.2649,"volume":536532085,"delay":0,"open":930.611,"prevYearClose":1190.107,"prevWeekClose":933.888,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":929.009,"twentyDayClose":928.063,"sixtyDayClose":909.52,"secType":"PLATE","market":"HK","turnoverRate":0.006128,"peRate":17.015388,"marketCap":620699252288,"floatMarketCap":517907756096,"timestamp":1788163726135,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":2,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660475137","title":"Iceland's Alvotech H1 Revenue Falls 31% on Manufacturing Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475137","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475137?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:14","pubTimestamp":1787174061,"startTime":"0","endTime":"0","summary":"Iceland's Alvotech H1 revenue falls 31% on manufacturing programOverviewIceland biosimilar medicines developer's H1 revenue fell 31% yr/yr due to manufacturing programAdjusted EBITDA declined as manuf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G129:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","01177","BK1191","HK0000165453.HKD","BK1589","IE00BZ08YS42.EUR","02696","HK0000320223.HKD","00656","HK0000306685.HKD","BK1521","IE00BZ08YT58.USD","HK0000306701.USD","BK1230","HK0000320264.USD","ALVO","BK1515","BK1161","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170810384","title":"Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1170810384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170810384?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150452,"startTime":"0","endTime":"0","summary":"Here are the key evening market developments investors need to know. NDRC Advances 'Six Networks' Infrastructure Plan On August 19, the National Development and Reform Commission (NDRC) held a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","82846","03188","BK1574","159938","BK1147","03130","02827","07233","83188","BK1515","399300","02846","159646","09939","BK1161","83130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178952366","title":"Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1178952366","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178952366?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150416,"startTime":"0","endTime":"0","summary":"Kintor Pharma-B (09939) has unveiled its interim financial results for the period ending June 30, 2026, showcasing a notable surge in revenue from RMB 6 million in the prior-year period to RMB 52...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09939","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660242429","title":"Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660242429","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660242429?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:33","pubTimestamp":1787149999,"startTime":"0","endTime":"0","summary":"Kintor net loss narrows 9% to RMB 75.8 million in 1H FY26; revenue rises to RMB 52 millionKintor posted revenue of RMB 52 million, up 766.7% year over year, driven by global sales of its KOSHIN cosmet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL7xt97N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429211","title":"Kintor Pharmaceutical H1 Revenue RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429211?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:32","pubTimestamp":1787149978,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXXDMDQT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150133670","title":"Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1150133670","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150133670?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:22","pubTimestamp":1787149350,"startTime":"0","endTime":"0","summary":"On August 19, a landmark moment arrived for tumor immunotherapy. Moderna and Merck announced that their phase III clinical trial, INTerpath-001, evaluating the tumor neoantigen mRNA vaccine mRNA-4157...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","159646","BK1574","09939","BK1515","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189494161","title":"Sinopharm Group and Partners to Divest 51% Stake in Guorui Pharma for RMB 406 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1189494161","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189494161?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:10","pubTimestamp":1787148656,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co., Ltd. (01099) has announced a significant divestment plan. On August 19, 2026, the company, along with its parent entity China National Pharmaceutical Group Corporation (Sinopharm...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","LU0640798160.USD","01099","BK1515","BK0010","BK0175","BK0082","BK0185","BK0188","BK0250","BK0028","BK0097","BK1197","LU1115378108.SGD","BK1500","600511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419426","title":"Sinopharm Sells 30.13% Stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419426","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660419426?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:00","pubTimestamp":1787148005,"startTime":"0","endTime":"0","summary":"Sinopharm sells 30.13% stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 millionSinopharm Group agreed to sell its 30.13% stake in Guorui Pharmaceutical to Shanghai Shyndec for RMB 240.07 mill","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL8qMG6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK0010","600420","BK1515","BK0239","01099","BK1197","LU1115378108.SGD","LU0640798160.USD","BK1500","BK0020","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660120426","title":"Sinopharm Group - to Sell 30.13% Stake in China National Medicines Guorui Pharmaceutical for Rmb240.0731 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2660120426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660120426?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:59","pubTimestamp":1787147985,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","LU0640798160.USD","01099","LU1115378108.SGD","BK1197","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161000321","title":"Regulator Approves New Audit Officer for Ping An Health Insurance Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=1161000321","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161000321?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:51","pubTimestamp":1787147495,"startTime":"0","endTime":"0","summary":"Financial news on August 19 reports that the National Financial Regulatory Administration has issued an official approval, confirming Zheng Yiwei's qualification to serve as the audit officer for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01833","BK1247","BK1571","BK1515","BK1219","BK1617","BK1615","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660400428","title":"Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2660400428","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660400428?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:19","pubTimestamp":1787141959,"startTime":"0","endTime":"0","summary":"Hong Kong's Sisram Medical H1 profit falls on China injectables investmentsOverviewHong Kong medical aesthetics firm's H1 revenue rose 3.6% yr/yr to $171.4 mlnNet profit and adjusted net profit declin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G0FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU0203345920.USD","BK1515","LU0289739343.SGD","IE000M9KFDE8.USD","BK1521","BK1593","LU0472753341.HKD","00656","LU2463526074.USD","BK4585","BK1585","BK4567","BK4149","IE00BZ08YT58.USD","LU0057025933.USD","SG9999015952.SGD","LU0511384066.AUD","LU0069063385.USD","LU0124676726.USD","BK1191","LU0689626769.HKD","SG9999015986.USD","CMI","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","IE00BZ08YS42.EUR","LU0154245673.USD","01177","LU2488822045.USD","BK1230","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015978.USD","LU0154245756.USD","BK4533","01696","00867","MADE","BK4588","SG9999004220.SGD","BK1589","IE00BMCWC346.EUR","IE00BZ08YR35.GBP","LU0289961442.SGD","LU0203347892.USD","BK1100","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660470794","title":"Sino Biopharmaceutical - Launches New Global Brand Sbp Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2660470794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660470794?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:28","pubTimestamp":1787138935,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","IE00BZ08YS42.EUR","BK1589","IE00BZ08YT58.USD","BK1191","BK1521","HK0000165453.HKD","01177","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440258","title":"Ping An Healthcare And Technology (SEHK:1833) Stock Sinks As Profitability Improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660440258?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:26","pubTimestamp":1787138777,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology has been treated like a high growth digital health platform with a valuation to match, yet the stock closed at HK$7.13 on 19 August, with the past three months delivering a decline of about 23%. Against that weaker share price, the H1 2026 headline is simple: the company stayed solidly profitable with basic earnings per share of ¥0.10 and net income of ¥219.3 million, while trailing net profit margin held at 8.5%. The market reaction and the income statement...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-stock-sinks-as-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-stock-sinks-as-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01833","BK1515","BK1571","BK4588","LABU","XLV","BK1615","BK1617","BK4581","HCSG","BK1219","BK4585","BK1247","BK1142","LU0128526141.USD","XBI","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106858532","title":"China Biopharmaceuticals (01177) Mid-Year Review: Betting Big on AI and Global Expansion as Twin Growth Engines","url":"https://stock-news.laohu8.com/highlight/detail?id=1106858532","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106858532?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:12","pubTimestamp":1787134322,"startTime":"0","endTime":"0","summary":"For an established pharmaceutical company already operating at massive commercial scale, the true challenge has never been expanding revenue—it's identifying the next source of growth. SBP Group...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","HK0000165453.HKD","BK1515","AIPO","BK1191","IE00BZ08YT58.USD","01177","BK1521","IE00BZ08YS42.EUR","BK1589","IE00BZ08YR35.GBP","VTHR","QTOC","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134175608","title":"SINOPHARM Reports Mid-Year Results for Its Medical Device Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=1134175608","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134175608?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:52","pubTimestamp":1787129544,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) has announced the interim financial results for its medical device subsidiary for the six-month period ending June 30, 2026.The unit recorded operating revenue of RMB 36.492...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","BK1500","LU0640798160.USD","01099","BK1515","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445799","title":"China National Medical Device, Sinopharm Subsidiary, Posts H1 Operating Profit Down 12.34% to RMB 599.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445799","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445799?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:47","pubTimestamp":1787129279,"startTime":"0","endTime":"0","summary":"China National Medical Device, Sinopharm subsidiary, posts H1 operating profit down 12.34% to RMB 599.37 millionSinopharm subsidiary China National Medical Device reported unaudited 1H 2026 revenue of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL64WTrr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","BK1500","LU0640798160.USD","LU1115378108.SGD","BK1515","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197235257","title":"BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths","url":"https://stock-news.laohu8.com/highlight/detail?id=1197235257","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197235257?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:36","pubTimestamp":1787128594,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) has announced that its majority-owned subsidiary, Guangzhou Baiyunshan Tiansin Pharmaceutical Co., Ltd., recently received the Drug Supplement Application Approval Notice from...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1191","BK1197","BK0183","BK0196","BK1515","BK1521","BK0012","BK0070","BK1574","BK0175","BK0096","BK0097","600332","BK0028","BK1606","00874","01477","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453474","title":"CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 1.3% to 8.69 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.CSPC Pharmaceutical Group Ltd. closed 25% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.1%, SSY Group Ltd. fell 0.6%, and United Laboratories International Holdings Ltd. fell 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 92.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1993786604.SGD","BK1191","IE0008368742.USD","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","KURE","LU0501845795.SGD","LU0072913022.USD","LU0067412154.USD","LU1951186391.HKD","LU0140636845.USD","LU0314109678.HKD","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226287529.USD","LU1226288170.HKD","BK1515","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YT58.USD","BK1521","LU0315179316.USD","HK0000165453.HKD","LU1226287875.USD","01093","LU1226288253.USD","LU0880133367.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445334","title":"Sino Biopharm Declares 2026 Interim Dividend of HKD 0.07 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445334","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445334?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:32","pubTimestamp":1787128333,"startTime":"0","endTime":"0","summary":"Sino Biopharm declares 2026 interim dividend of HKD 0.07 a shareSino Biopharmaceutical declared an interim dividend of HKD 0.07 per share for the financial year ending Dec. 31, 2026.Shares trade ex-di","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2RtsXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1521","BK1589","IE00BZ08YR35.GBP","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445369","title":"Sino Biopharmaceutical H1 Revenue RMB 1,944 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445369?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:32","pubTimestamp":1787128328,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXTBNC50:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1521","HK0000165453.HKD","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1589","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":13,"totalSize":284,"code":"91000000","status":"200"}]}}